Skip to content Skip to sidebar Skip to footer


CollPlant receives $10m milestone payment for regenerative collagen technology

Regenerative and aesthetic medicine company CollPlant Biotechnologies ((NASDAQ: CLGN) has reached a significant milestone in its collaboration with pharma giant AbbVie for the development of a regenerative dermal and soft tissue filler product. Reaching the milestone triggers a $10 million payment to CollPlant. The collaboration between CollPlant and AbbVie began in 2021 when the entered…

Read More

AbbVie, Deere And A Major Chipmaker Set To Win In AI: CNBC’s ‘Final Trades’ – Broadcom (NASDAQ:AVGO), AbbVie (NYSE:ABBV)

On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management said AbbVie Inc. ABBV has a 4.5% yield and high free cash flow yield. AbbVie reported reimbursement for VRAYLAR for the treatment of schizophrenia under Non-Insured Health Benefits (NIHB) Program. Stephen Weiss of Short Hills Capital…

Read More